{
    "title": "FDA approves cancer therapy by J&J, partner Legend Biotech",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10563311/FDA-approves-cancer-therapy-J-J-partner-Legend-Biotech.html",
    "date": "2022-03-01",
    "keywords": [
        "therapy",
        "drug",
        "china",
        "cancer",
        "legend",
        "jampj",
        "health",
        "regulator",
        "johnson",
        "biotech",
        "cell",
        "decision",
        "time",
        "japan",
        "officer",
        "carvykticiltacel",
        "cart",
        "split",
        "profit",
        "reporting",
        "amp",
        "partner",
        "corp",
        "type",
        "blood",
        "company",
        "monday",
        "food",
        "way",
        "product",
        "scrutiny",
        "legendjampj",
        "pipeline",
        "disease",
        "huang",
        "treatment",
        "class",
        "antigen",
        "receptor",
        "tcell",
        "work",
        "engineering",
        "attack",
        "httpsbitly3c1cfns",
        "end",
        "november",
        "priority",
        "review",
        "information",
        "request",
        "development",
        "agreement",
        "janssen",
        "arm",
        "payment",
        "marketing",
        "authorisation",
        "application",
        "maa",
        "leo",
        "shivani",
        "tanna",
        "sneha",
        "bhowmik",
        "bhargav",
        "acharya",
        "kalluvila",
        "subhranshu",
        "sahu",
        "sherry"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}